COMMUNICATIONS
has antiarrhythmic properties.[2] On the basis of extensive
NMR spectroscopic experiments, its structure and relative
stereochemistry were reported as the zwitterion 1 (Scheme 1)
with a novel azatricyclic skeleton.[1] Although its specific
rotation value in a chloroform solution was reported to be
zero, it was believed that lepadiformine is not racemic.
However, the absolute configuration has remained hitherto
unknown. The unique structural features and biological
significance of this novel marine alkaloid have made it an
important target for synthesis. Weinreb and co-workers[3]
reported the synthesis of the structure 1 proposed for
lepadiformine and found that the synthetic material exists as
a nonzwitterionic form 2 and that neither the free amine nor
its hydrochloride salt corresponds to the natural product.
Moreover, Pearson et al.[4] synthesized the other three C3/C5
diastereomers of 2 and found that they different from
lepadiformine (Scheme 1). Following these synthetic efforts,
we recently published the total synthesis of compound 3 in the
racemic form, based on an intramolecular acylnitroso Diels
Alder-based approach and found by spectral comparison that
the corresponding hydrochloride salt was identical to the
reported natural product.[5] We thus concluded that the
originally assigned structure of lepadiformine was actually
that of the hydrochloride salt and that its relative stereo-
chemistry should be revised to be that of 3 (Scheme 1).
[6] a) For an excellent review of Lewis acid mediated radical reactions,
see: P. Renaud, M. Gerster, Angew. Chem. 1998, 110, 2704; Angew.
Chem. Int. Ed. 1998, 37, 2562; for recent examples of Lewis acid
promoted atom-transfer radical reactions, see: b) C. L. Mero, N. A.
Porter, J. Am. Chem. Soc. 1999, 121, 5155; c) A. J. Clark, F. D. Campo,
R. J. Deeth, R. P. Filik, S. Gatard, N. A. Hunt, D. Lastecoueres, G. H.
Thomas, J.-B. Verlhac, H. Wongtap, J. Chem. Soc. Perkin Trans. 1 2000,
671; d) O. Kitagawa, H. Fujiwara, T. Taguchi, Tetrahedron Lett. 2001,
42, 2165; e) O. Kitagawa, Y. Yamada, H. Fujiwara, T. Taguchi, J. Org.
Chem. 2002, 67, 922.
[7] For details about side products, see Supporting Information.
[8] For examples on the use of 4-ä molecular sieves in asymmetric
reactions, see: a) R. M. Hanson, K. B. Sharpless, J. Org. Chem. 1986,
51, 1922; b) K. Narasaka, N. Iwasawa, M. Inoue, T. Yamada, M.
Nakashima, J. Sugimoto, J. Am. Chem. Soc. 1989, 111, 5340; c) K.
Mikami, M. Terada, T. Nakai, J. Am. Chem. Soc. 1990, 112, 3949;
d) D. A. Evans, M. M. Faul, M. T. Bilodeau, B. A. Anderson, D. M.
Barnes, J. Am. Chem. Soc. 1993, 115, 5328; e) T. Iida, N. Yamamoto,
H. Sasai, M. Shibasaki, J. Am. Chem. Soc. 1997, 119, 4783.
[9] For recent reviews on lanthanide Lewis acids catalysis, see: a) S.
Kobayashi, Synlett 1994, 689; b) M. Shibasaki, K.-I. Yamada, N.
Yoshikawa in Lewis Acids in Organic Synthesis, Vol. 2 (Ed: H.
Yamamoto), Wiley, New York, 2000, chap. 20, p. 911.
[10] For recent reviews on the use of C2-symmetric chiral bisoxazoline
ligands in asymmetric catalysis, see: a) A. Pfaltz, Acta Chem. Scand.
1996, 50, 189; b) A. K. Ghosh, P. Mathivanan, J. Cappiello, Tetrahe-
dron: Asymmetry 1998, 9, 1; c) J. S. Johnson, D. A. Evans, Acc. Chem.
Res. 2000, 33, 325.
[11] a) For a recent review on the effect of additives on asymmetric
reactions, see: E. M. Vogl, H. Grˆger, M. Shibasaki, Angew. Chem.
1999, 111, 1672; Angew. Chem. Int. Ed. 1999, 38, 1570; for examples of
the additive effect in chiral ytterbium triflate mediated asymmetric
reactions, see: b) S. Kobayashi, H. Ishitani, J. Am. Chem. Soc. 1994,
116, 4083; c) S. Kobayashi, H. Ishitani, I. Hachiya, M. Araki,
Tetrahedron 1994, 50, 11623; d) T. Saito, M. Kawamura, J.-I.
Nishimura, Tetrahedron Lett. 1997, 38, 3231; e) M. Kawamura, S.
Kobayashi, Tetrahedron Lett. 1999, 40, 3213.
7a
11a
N+
3
N
[12] D. A. Evans, Z. K. Sweeney, T. Rovis, J. S. Tedrow, J. Am. Chem. Soc.
2001, 123, 12095.
5
H
HO
O–
2
1
HO
Total Synthesis of the Natural Enantiomer of
(ꢀ)-Lepadiformine and Determination of Its
Absolute Stereochemistry**
N
N
H
H
Hideki Abe, Sakae Aoyagi, and Chihiro Kibayashi*
HO
Lepadiformine was isolated by Biard et al. in 1994from the
marine tunicates Clavelina lepadiformis collected in Tunisia[1]
and from Clavelina moluccensis found along the Djibouti
coast.[2] It has been shown to exhibit moderate cytotoxic
activity against various tumor cell lines in vitro.[1] Moreover, a
recent study indicated that lepadiformine is very active in the
cardiovascular system in vivo and in vitro and suggested that it
3
Scheme 1. The originally proposed structure of lepadiformine was that of
1. The revised structure is that of 3.
After establishment of the relative stereochemistry, two
syntheses of racemic lepadiformine were reported by the
groups of Weinreb[6] and Funk[7] based on a spirocyclization of
an allylsilane N-acyliminium ion and on a amidoacrolein-
derived Diels Alder reaction, respectively. However, because
the natural product is not crystalline and its derivatives could
not be prepared, efforts to obtain an X-ray structure of
natural lepadiformine for the determination of the absolute
configuration have so far been unsuccessful.[1,8] This prompted
us to undertake the enantioselective synthesis of lepadifor-
mine and to determine the absolute configuration of the
natural product.
[*] Prof. Dr. C. Kibayashi, H. Abe, S. Aoyagi
School of Pharmacy, Tokyo University of Pharmacy & Life Science
1432-1 Horinouchi, Hachioji, Tokyo, 192-0392 (Japan)
Fax : (þ 81)426-76-4475
E-mail: kibayasi@ps.toyaku.ac.jp
[**] This work was supported in part by a Grant for Private Universities
provided by the Ministry of Education, Sports, and Culture of Japan
and the Promotion and Mutual Aid Corporation for Private Schools of
Japan. We are grateful to Professor J. F. Biard for a sample of natural
lepadiformine.
Angew. Chem. Int. Ed. 2002, 41, No. 16
¹ 2002 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
0044-8249/02/4116-3017 $ 20.00+.50/0
3017